Agarwal, Sameer <br/><br/>
Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes.  [electronic resource] 

 -  Bioorganic & medicinal chemistry letters  06 2018 
 - 1849-1852 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1464-3405 
<br/><br/><label>Standard No.: </label>10.1016/j.bmcl.2018.04.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Binding Sites<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Drug Therapy, Combination<br/>Female<br/>Glucagon-Like Peptide 1--metabolism<br/>Half-Life<br/>Humans<br/>Hypoglycemic Agents--chemistry<br/>Imidazoles--chemistry<br/>Mice<br/>Mice, Inbred C57BL<br/>Molecular Docking Simulation<br/>Protein Structure, Tertiary<br/>Receptors, G-Protein-Coupled--agonists<br/>Sitagliptin Phosphate--therapeutic use<br/>Structure-Activity Relationship